🇺🇸 FDA

Company profile · Sponsor

Esperion

Esperion Therapeutics

ESPR · NYSE pharma ANN ARBOR, MI, USA
Pipeline
15
Drugs
1
Patents
8

Quick answer

Esperion (ESPR) is a pharma company. headquartered in ANN ARBOR, MI, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 1 drug, and 8 patents to this profile..

Company facts

Ticker ESPR
Exchange NYSE
Company type pharma
Headquarters ANN ARBOR, MI, USA
SEC CIK 0001434868

Pipeline (15)

Search pipeline →

  1. Bempedoic Acid + Ezetimibe Fixed-Dose Combination

    Esperion

    Hyperlipidemias

    phase 3 other completed

    1 trial

  2. Bempedoic acid 180 mg tablet

    Esperion

    Cardiovascular Diseases

    phase 3 small molecule completed

    1 trial

  3. ETC-1002

    Esperion

    Hypercholesterolemia

    phase 3 small molecule completed

    6 trials

  4. bempedoic acid

    Esperion

    Hypercholesterolemia

    phase 3 small molecule completed

    5 trials

  5. Bempedoic acid + Ezetimibe FDC Oral Tablet

    Esperion

    Diabetes

    phase 2 small molecule completed

    1 trial

  6. Bempedoic acid 180mg

    Esperion

    Hypercholesterolemia

    phase 2 small molecule completed

    2 trials

  7. Bempedoic acid, bempedoic acid

    Esperion

    Heterozygous familial hypercholesterolemia, Heterozygous Familial Hypercholesterolemia

    phase 2 small molecule active

    1 trial

  8. ETC-1002

    Esperion

    Hyperlipidemia

    phase 2 small molecule completed

    2 trials

  9. ETC-1002

    Esperion

    Dyslipidemia

    phase 2 small molecule completed

    1 trial

  10. ETC-1002

    Esperion

    Safety Evaluation of Escalating Doses

    phase 1 small molecule completed

    1 trial

  11. ETC-1002 or placebo

    Esperion

    Mild Dyslipidemia

    phase 1 small molecule completed

    1 trial

  12. [14C-ETC-1002]

    Esperion

    Hyperlipidemia

    phase 1 small molecule completed

    1 trial

  13. Bempedoic Acid / Ezetimibe Oral Tablet

    Esperion

    Cardiovascular Diseases

    approved small molecule active

    1 trial

  14. Bempedoic Acid 180 MG Oral Tablet

    Esperion

    Healthy Lactating Women

    approved small molecule completed

    1 trial

  15. Cardiopulmonary Exercise Testing

    Esperion

    Intrauterine Growth Restriction

    other active

    1 trial

Drugs (1)

Search drugs →

  1. bempedoic acid

    NILEMDO

    ORAL approved

    C10B

Patents (8)

Search patents →

  1. US 12404227

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Aug 28 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12398087

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12344578

    Salt forms of bempedoic acid and methods for using the same

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11987548

    Methods of making bempedoic acid and compositions of the same

    Expires Mon May 16 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11926584

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11760714

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11744816

    Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11613511

    Methods of making bempedoic acid and compositions of the same

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Esperion?

Esperion (ESPR) is a pharma company. headquartered in ANN ARBOR, MI, USA. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 1 drug, and 8 patents to this profile..

What pipeline programs does Esperion sponsor?

We track 15 ClinicalTrials.gov-linked programs for Esperion, including Bempedoic Acid + Ezetimibe Fixed-Dose Combination and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Esperion company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.